---
title: "Policy Pulse — Trump / US — 13 Aug 2026"
ticker: "QQQ:SMCI:NVDA:MSFT:GOOGL:META:CRWV:DJT:XOM:CVX:OXY:DAL:UAL:CCL"
date: "2026-08-13"
tags: ["policy-pulse","us-only","trump","ai","fed","crude","hormuz","djt"]
summary: "AI rally carries US stocks toward records as oil eases (Brent ~87.7); Truth API hit by a First-Amendment lawsuit; S&P near record, Nasdaq 100 +1.2%"
model: "deepseek-chat"
---

# Policy Pulse — Trump / US — 13 Aug 2026

## 🇺🇸 AI Rally Carries US Stocks Toward Records as Oil Eases; Truth API Hit by a First-Amendment Lawsuit

US equities kept climbing Thursday (Aug 13) after the tame CPI print — **S&P 500 +0.4–0.6% near a record**, **Dow +0.2–0.3%**, and the **Nasdaq 100 +0.9–1.2%** led by AI/tech buying as **Treasury 2-year yields fell to ~4.13%**, reinforcing expectations that the **Fed will NOT raise rates next month**. The **AI-infrastructure trade** stays in the driver's seat (CoreWeave +18% on Aug 12, Super Micro, and the ~$1.6T AI-capex narrative). Aiding the tape, **oil prices dropped** — Brent fell ~$1.3 to **~$87.7** and WTI to **~$82** on a surprise **US crude inventory build**, the first real pullback after crude's run to a two-week high.

Separately, **Trump Media (DJT)** is facing its first legal knock on the **Truth API** product. The Intercept and the Freedom of the Press Foundation (and a coordinated companion filing) sued in **Manhattan federal court**, arguing that **selling $100K/month early access to the Truth Social feeds of 10 high-profile accounts (including Trump's own) — whose posts "often move financial markets"** — violates the First Amendment and effectively **sells/speeds access to presidential communications** (with insider-trading-style concerns). This is a **fresh headwind** to the B2B revenue story that lifted DJT sentiment around the Aug 1 Truth API launch.

| Stock | Impact | Reason |
|-------|--------|--------|
| QQQ / SMCI / NVDA / MSFT / GOOGL / META | 🟢 BUY | Nasdaq 100 +0.9-1.2% on continued AI/tech buying; 2-yr yield ~4.13% keeps the Fed on hold — AI-capex trade extends |
| SPY / DJIA | 🟢 Watch | S&P 500 near record / Dow +0.2-0.3% on inflation-cooling + lower oil |
| CRWV (CoreWeave) | 🟢 Buy | Up 18% Aug 12 (Q2 revenue doubled); anchor of the AI-buildout trade |
| DJT (Trump Media) | 🟡 Watch-Negative | **First-Amendment lawsuit over Truth API** ($100K/mo early feed); legal risk to the B2B revenue catalyst, but no ruling yet |
| XOM / CVX / OXY / HAL / SLB / USO | 🟡 Two-way | Brent fell to ~$87.7 on a 17.4M-barrel US inventory build — crude-backed pull from highs |
| DAL / UAL / AAL / LUV / CCL / RCL / NCLH | 🟢 Watch | Lower oil is a mild fuel-cost relief after days of $88-90 crude |
| TEVA / MYL | 🔴 Watch | Generics remain under the structural Section 301/232 + phased generic-drug tariff regime (0% → 100% → 200%) |

### 📊 US Market Context (Aug 13)
- **Indices:** S&P 500 +0.4-0.6% near record; Dow +0.2-0.3%; **Nasdaq 100 +0.9-1.2%** (AI/tech led).
- **Rates:** **2-yr Treasury yield down to ~4.13%** — markets confirming the Fed likely holds in September.
- **Crude:** **Brent ~$87.7 (-$1.3), WTI ~$82** on a surprise **17.4M-barrel US crude inventory build** — first real pullback after a streak of gains; Hormuz still a two-way overhang.
- **DJT catalyst:** **Truth API lawsuit** (Intercept + Freedom of the Press Foundation, Manhattan federal court) — challenges the paid early-access feed that "often moves financial markets."

> Country rule applied: **US stocks only**. No **new Trump personal-equity-trade** disclosure surfaced today beyond the re-reported Q1/Q2 278-T filings (not republished per standing practice).

### ⚠️ What to Watch Next
- **Fed path:** tame CPI + soft yields keep a **September hold** on; a hot services print or Hormuz-driven oil pass-through would re-awaken hike bets.
- **Crude:** the inventory-driven pullback is a **tactical** move — a decisive break lower needs a **SIGNED** Hormuz reopening (flips energy/airline three-way).
- **DJT/Truth API:** watch for a courtroom ruling or any pause on the API; also the Sep 18 crypto-ETF decision.
- Recurring — **Sep 29** medical-device Section 232 tariffs; **Nov 2026** midterms; ongoing Section 301 tariff administration (India on the lower 10% tier).